Product: Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx Product, ProRx 267-565-7008, NDC 84139-210-01
Reason for recall: Lack of Assurance of Sterility
Recall initiated: 20240822
Status: Ongoing
Classification: Class II
Recall type: Voluntary: Firm initiated